Neo May 11, 2024, 4:09am #1 IMG_728811791181 187 KB Functional and multi-omic aging rejuvenation with GLP-1R agonism Importantly, the beneficial effects are specific to aged mice, not young adults, and are achieved with a low dosage of GLP-1RA which has a negligible impact on food consumption and body weight
Originally marketed for diabetes management, the drug is now used for weight loss in teens and adults
Spinal decompression therapy is designed to reduce pressure within spinal discs
In UM microenvironment, PKC and Ras protein activator RasGRPs together activate MAPK signal, which is an important mechanism of inducing tumor cell growth
However, both of these drugs are GLP-1 agonists, which bind to GLP-1 receptors, simulate a feeling of satiety, and signal the pancreas to produce insulin
Table 14: Summary of Key Model Parameters GLP-1 = glucagon-like peptide 1